22% af de inkluderede patienter fik samtidig lavdosis acetylsalicylsyre (≤ 325 mg/ dag), primært som kardiovaskulær profylakse.
Twenty-two percent of enrolled patients took concomitant low-dose acetylsalicylic acid (≤ 325 mg/ day), 26 primarily for cardiovascular prophylaxis.